SNCA and Parkinson disease: Among them, nodes such as alpha-synuclein, neurodegeneration, and neuroinflammation reveal the key pathological processes of abnormal protein aggregation causing neuroinflammation and neuronal damage in PD, and these processes are precisely the important targets of current immunotherapy (21–26).